Hope for the Future in Black Myeloma- A Black Myeloma Health Panel
![Hope for the Future in Black Myeloma- A Black Myeloma Health Panel image](https://healthtree.org/images-resize?width=1000&height=1000&imageUrl=https%253A%252F%252Ffirebasestorage.googleapis.com%252Fv0%252Fb%252Fhealthtree-production.appspot.com%252Fo%252Fgallery%25252Fpublic%25252FBlack%252520Myeloma%252520Health%252520Feb%2525202024%252520Event_77343abb-85d3-4bff-ae24-86907957f842.png%253Falt%253Dmedia)
Event Description
This Black History Month, we are excited to host our second annual Hope for the Future in Black Myeloma Virtual RoundTable Event, and will feature three Black myeloma experts in this year’s panel.
Join us as we hear about exciting advancements in the MGUS/smoldering, newly diagnosed, and relapsed/refractory myeloma fields from Drs. Monique Hartley-Brown, Ayo Fatoki, and Brandon Blue.
Learn how immunotherapies are or could be used in each of these stages, what other novel therapies are available, and why each of these patients and their loved ones have reasons to hope.
Schedule & Agenda
![The panelist Valarie Traynham](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FValarie%20Traynham_6ee05222-9767-4de3-8db0-b94f2c86f483.jpg?alt=media)
Valarie introduces the agenda of the event and our featured speakers Dr. Ayo Fatoki, Dr. Monique Hartley-Brown and Dr. Brandon Blue.
![The panelist Valarie Traynham](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FValarie%20Traynham_6ee05222-9767-4de3-8db0-b94f2c86f483.jpg?alt=media)
Valarie introduces the agenda of the event and our featured speakers Dr. Ayo Fatoki, Dr. Monique Hartley-Brown and Dr. Brandon Blue.
![The panelist Monique Hartley-Brown, MD](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FMonique%20Hartley-Brown_7dc96123-1d5f-4def-a280-280d9fbc2e7c.jpg?alt=media)
Dr. Hartley-Brown shares her insights on how recent advancements in the precursor myeloma field can give hope to MGUS and smoldering myeloma patients.
![The panelist Monique Hartley-Brown, MD](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FMonique%20Hartley-Brown_7dc96123-1d5f-4def-a280-280d9fbc2e7c.jpg?alt=media)
Dr. Hartley-Brown shares her insights on how recent advancements in the precursor myeloma field can give hope to MGUS and smoldering myeloma patients.
![The panelist Raleigh Ayo Fatoki, MD, MBA](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FRaleigh%20Ayo%20Fatoki,%20MD,%20MBA_510d4f6a-e430-41a4-b903-a432c5ef7482.jpg?alt=media)
Dr. Fatoki shares his insights on how recent advancements in the newly diagnosed myeloma field can give hope to patients.
![The panelist Raleigh Ayo Fatoki, MD, MBA](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FRaleigh%20Ayo%20Fatoki,%20MD,%20MBA_510d4f6a-e430-41a4-b903-a432c5ef7482.jpg?alt=media)
Dr. Fatoki shares his insights on how recent advancements in the newly diagnosed myeloma field can give hope to patients.
![The panelist Brandon Blue, MD](https://storage.googleapis.com/crowdnews-media-library/fab1c150-1b25-428c-9d52-2cd9fdab9a1a.jpg)
Dr. Blue shares his insights on how recent advancements in the relapsed/refractory myeloma field can give hope to patients.
![The panelist Brandon Blue, MD](https://storage.googleapis.com/crowdnews-media-library/fab1c150-1b25-428c-9d52-2cd9fdab9a1a.jpg)
Dr. Blue shares his insights on how recent advancements in the relapsed/refractory myeloma field can give hope to patients.
Type your questions in the chat and we will answer them!
Type your questions in the chat and we will answer them!
Speakers & Moderators
![The panelist Valarie Traynham](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FValarie%20Traynham_6ee05222-9767-4de3-8db0-b94f2c86f483.jpg?alt=media)
Valarie embarked on her myeloma journey back in 2015, and ever since she's been on a mission. As a resilient myeloma thriver, her passion lies in not just navigating her own path but also in illuminating the journey for others. With a steadfast commitment to understanding the intricacies of the disease, she champions education, shedding light on health inequities that often lurk in the shadows. Driven by a profound belief in fairness, Valarie tirelessly advocates for equitable access to top-tier healthcare, clinical trials, and tailored treatments. Her journey as a beacon of knowledge and support began when she assumed the role of a support group leader. Today, she continues to extend her hand as a myeloma coach, mentor angel, and the guiding force behind the Black Myeloma Health Community. Valarie's voice echoes far and wide as she fearlessly confronts the disparities faced by myeloma patients. Through collaborative efforts with healthcare providers, she strives to forge pathways to solutions, ensuring that every individual receives the care they deserve. Join Valarie on her journey of empowerment and advocacy as she lights the way toward a brighter, more equitable future in myeloma care.
![The panelist Raleigh Ayo Fatoki, MD, MBA](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FRaleigh%20Ayo%20Fatoki,%20MD,%20MBA_510d4f6a-e430-41a4-b903-a432c5ef7482.jpg?alt=media)
Raleigh Ayo Fatoki, MD, MBA is a Hematology-Oncology fellow at the University Miami-Sylvester Comprehensive Cancer Center. His research interests include Multiple Myeloma and the biological drivers of disparities in people of African descent. Dr. Fatoki studied Economics at Howard University before completing a joint MD/MBA program at Meharry Medical College and Vanderbilt University Owen Graduate School of Management. He trained in Internal Medicine with Kaiser Permanente in Oakland, CA.
![The panelist Brandon Blue, MD](https://storage.googleapis.com/crowdnews-media-library/fab1c150-1b25-428c-9d52-2cd9fdab9a1a.jpg)
Dr. Brandon Blue is an assistant professor at the Moffitt Cancer Center in Tampa, FL. His clinical interests include treatment of plasma cell disorders and evaluation of patients pre and post bone marrow transplant. His research interests include reducing health disparities and improving health outcomes for plasma cell dyscrasias. Dr. Blue recently completed a Blood and Marrow Transplant and Cellular Immunotherapy Fellowship at Moffitt Cancer Center. Dr. Blue recently completed a Blood and Marrow Transplant and Cellular Immunotherapy Fellowship at Moffitt Cancer Center. He completed an Internal Medicine Residency in the Department of Medicine at Washington University School of Medicine, St. Louis, MO, and a Hematology/Oncology Fellowship in the Department of Medicine at Saint Louis University School of Medicine. He earned his MD at Meharry Medical College, Nashville, TN.
![The panelist Monique Hartley-Brown, MD](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FMonique%20Hartley-Brown_7dc96123-1d5f-4def-a280-280d9fbc2e7c.jpg?alt=media)
Dr. Hartley-Brown is an emerging leader in the field of Multiple Myeloma. She is an Associate Physician at Harvard Medical School and Assistant Professor & Medical Oncologist who specializes in treating patients with multiple myeloma. She practices clinical care at the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. Multiple myeloma is an incurable cancer that affects Black Americans approximately twice more than Caucasians. Dr. Hartley-Brown has written several publications and has been a clinical research investigator for numerous clinical studies that has contributed to the advancement of clinical care for patients with multiple myeloma and plasma cell dyscrasias. As a Black female physician, she is dedicated to ensuring that the care for the myeloma community is equitable and affords all patients with myeloma an optimal level of care regardless of background, race or socioeconomic status.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org
![newsletter icon](https://static.healthtree.org/icons/newsletter-icon.png)
Get the latest thought leadership on your Anaplastic Large Cell Lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.